Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.
about
Salivary Secretory Disorders, Inducing Drugs, and Clinical ManagementTreatment of primary Sjögren syndrome.Sialendoscopic management of autoimmune sialadenitis: a review of literature.Efficacy and economic evaluation of pilocarpine in treating radiation-induced xerostomia.Primary Sjögren's syndrome: new clinical and therapeutic conceptsLamivudine is not effective in primary Sjögren's syndrome.Xerostomia: clinical aspects and treatment.Effect of yogurt and pH equivalent lemon juice on salivary flow rate in healthy volunteers - An experimental crossover study.The management of Sjögren's syndrome.Cevimeline (Evoxac ®) overdoseOral manifestations of Sjögren's syndrome.Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD.Sjögren's syndrome in older patients: aetiology, diagnosis and management.Oral manifestations and their treatment in Sjögren's syndrome.Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca.Current Approach to Dry Eye Disease.Recommendations for the treatment of Sjögren's syndrome.Safety of treatments for primary Sjögren's syndrome.[Liposomal local therapy as treatment for sicca symptoms in patients with primary Sjögren's syndrome].Primary Sjögren's syndrome: diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system.Effect of the H2 receptor antagonist nizatidine on xerostomia in patients with primary Sjögren's syndrome.Protective effects of polysaccharides and polyhydric alcohols in a dry mouth model in cultured cells.Significant increase in salivary substance p level after a single oral dose of cevimeline in humans.Current and prospective treatment options for Sjögren's syndrome.New approaches in Sjögren's syndrome therapy.Transplantation of cultured salivary gland cells into an atrophic salivary gland.Effect of cevimeline on salivary components in patients with Sjögren syndrome.Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia.Topical and systemic medications for the treatment of primary Sjögren's syndrome.Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.Low-level laser therapy for xerostomia in primary Sjögren's syndrome: a randomized trial.Evaluation of Swallowing Functions in Patients with Sjögren's Syndrome.A controlled release pilocarpine buccal insert in the treatment of Sjögren's syndrome.Contribution of HIV Infection, AIDS, and Antiretroviral Therapy to Exocrine Pathogenesis in Salivary and Lacrimal Glands
P2860
Q26777907-346DDAF7-2893-478C-A759-EDD4BE5124CDQ30249011-41B759C2-9E26-4154-8412-A6491B2AA706Q33777026-0B994AD5-22DE-4C8E-B2BA-151DF8BAA725Q35207574-2198255E-9C03-4332-A5E1-B25E09B955C3Q35555323-DC13787C-E39E-4669-B84B-86CE96AF901CQ35556009-A815CA5D-92D4-497A-9C46-A02B1B852677Q35617038-67808E92-3F21-4484-B9F1-20D9F8A9AF13Q36429972-5125E905-7FB8-4AD5-A3C5-BA9D6F517BB5Q36577478-A19AB485-FA18-4835-B371-12FB7F160880Q36734012-B9572566-76F3-481A-AD74-888B2CDB0006Q37117336-208E6513-7573-4EEE-B897-2225C10BAEFAQ37791005-2E94A120-BDA4-4597-97D7-0D372F5F5DC9Q38076070-748EA0F0-B7AE-4700-AD96-CA9041BC8849Q38096005-325F8134-E590-489E-A87F-7C8BAE962663Q38176265-FBFD0BA2-EA31-4F4C-B0BA-5A879C08EF30Q38235721-59718A91-77D9-417E-8B44-7F293803FCE0Q38584878-6ECB4DC7-0B78-4238-BD83-A0921F53764CQ38711144-B816D86E-5651-49FC-8C77-0E331BFE0534Q39223579-B343A45C-8D4B-4599-AC4E-10EBD47F7739Q39294614-5678226A-B477-43AE-B1B7-E7D394AEB150Q39319897-595FEF1D-E426-4EBA-BAE2-905F40406642Q39561316-77C484CB-3A95-4187-A78D-C5B1CE5D9C51Q39711364-33A100B8-DFC5-4118-9EEF-2FADBE3AFD5CQ40076686-4726E38B-CA62-4CEA-90C8-2120DDC5BE32Q40238844-11107D54-02BF-4466-9506-FCAEDCD4612AQ42819359-9CE82846-0CC4-4A5D-99BB-704EBEC3FE3DQ43514179-0A2CA67C-35C6-4C18-8920-2C9E6CDDF7FCQ44222360-97975A6A-AA52-4626-82AA-40E4EB222BF9Q44498935-890D4123-3733-4822-A998-B2F9544200C6Q46006385-5EEB1334-7252-4EA0-B667-40F92868A373Q47222437-3D28B5C5-5888-403D-9BD1-04B1B7902327Q48035705-4F05EE4B-D9C0-4FE0-BB6F-B3DE6B22990FQ53579301-3DF16138-BB6F-42B7-8BC2-19B85DFB6D6BQ58742470-075B51F6-67D1-43FB-9FCB-3E8E7C5E9551
P2860
Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Cevimeline for the treatment o ...... syndrome: a randomized trial.
@en
Cevimeline for the treatment o ...... syndrome: a randomized trial.
@nl
type
label
Cevimeline for the treatment o ...... syndrome: a randomized trial.
@en
Cevimeline for the treatment o ...... syndrome: a randomized trial.
@nl
prefLabel
Cevimeline for the treatment o ...... syndrome: a randomized trial.
@en
Cevimeline for the treatment o ...... syndrome: a randomized trial.
@nl
P2093
P1476
Cevimeline for the treatment o ...... syndrome: a randomized trial.
@en
P2093
Craig W Wiesenhutter
Elizabeth Tindall
James Y Suen
Peter B Lockhart
Robin K Dore
Rose S Fife
Walter F Chase
P304
P356
10.1001/ARCHINTE.162.11.1293
P407
P577
2002-06-01T00:00:00Z